Lung transplant study: comparing two ECMO methods
Part of Lungs & breathing clinical trials.
This study compares two ways of using a heart-lung machine (ECMO) during lung transplant surgery. The goal is to see if using ECMO only when needed works as well as using it for everyone. This could help reduce risks and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to receive a lung transplant.
- You can give your own permission to be in the study.
- This is your first lung transplant (not a retransplant).
- You are not receiving a transplant for more than one organ (like heart and lung together).
- You are able to take standard blood-thinning medication (heparin).
- You do not have severe lung blood pressure (pulmonary hypertension) or heart problems that would require ECMO support during surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at using a heart–lung machine (ECMO) to reduce complications and deaths after a lung transplant. It focuses on people getting a lung transplant who have certain types of lung-vessel (pulmonary) pressure problems.
This study compares two ways of supporting the lungs and heart around the time of a double lung transplant: venoarterial ECMO versus an off-pump approach. It may help your team choose the safest support method based on your heart-lung pressures and surgical plan.
This trial tests two different ways of using a breathing machine to protect the lungs in people who are on ECMO (a machine that adds oxygen to the blood) for severe ARDS (a serious lung condition). If you qualify, you might get a treatment approach that could help your lungs heal better.
This study tests a special heart-lung support machine (ECMO) for people waiting for a lung transplant whose heart is failing due to high blood pressure in the lungs. The machine helps rest the heart and lungs until transplant surgery.
This study compares two different blood thinners (UFH and LMWH) used during heart-lung bypass (ECMO) for double lung transplant patients. The goal is to see which one works better and is safer.
This study looks at ways to improve breathing and blood flow in patients who are on a heart-lung machine (ECMO) for severe heart problems. It may help doctors better manage care for people in intensive care.
Hear when a new Respiratory Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.